Better Pharma Growth Stock: Eli Lilly vs. Merck

Eli Lilly (NYSE: LLY) and Merck (NYSE: MRK) are both among the largest biopharmaceutical businesses in the world, but their growth prospects aren't exactly the same. Let's explore which of the pair is the better pharma growth stock, so that you can see whether one or both could be a beneficial pickup for your portfolio. The case for Eli Lilly being the better pharma growth stock rests on the medications that it's planning to commercialize within the next year or so, as well as on the continued expansion of one of its freshly launched high-earning drugs.